Investigation in nephrotic syndrome
"nephrotic syndrome" AND "investigations" AND "diagnosis"
| Pattern | Interpretation |
|---|---|
| C3 ↓, C4 ↓, CH50 ↓ | Classical pathway - SLE nephritis, cryoglobulinemia, MPGN type I |
| C3 ↓, C4 normal, CH50 ↓ | Alternative pathway - poststreptococcal GN, endocarditis, shunt nephritis, DDD |
| C3 normal, C4 normal | MCD, FSGS, membranous nephropathy, IgA nephropathy |
| Population | Approach |
|---|---|
| Adults with idiopathic NS | Biopsy required - glomerular pathology cannot be predicted by clinical features alone |
| Children aged 1-12 years | Presumptive diagnosis of MCD; treat with steroids without biopsy if typical presentation |
| Children with atypical features | Biopsy indicated (microhematuria, hypocomplementemia, reduced GFR, steroid resistance/dependence, age <1 year, macroscopic hematuria, hypertension, extrarenal features) |
| Adults with positive anti-PLA2R | May support diagnosis of primary MN - biopsy still provides chronicity data |
| Category | Test | Purpose |
|---|---|---|
| Urine | Dipstick, PCR/ACR, 24h protein, microscopy | Confirm nephrotic range proteinuria; lipiduria |
| Blood | Albumin, creatinine, electrolytes, lipids, CBC | Confirm syndrome, assess complications |
| Coagulation | PT, APTT, fibrinogen, AT-III | Hypercoagulable state |
| Complement | C3, C4, CH50 | Narrow differential |
| Immunology | ANA, anti-dsDNA, ANCA, anti-GBM, anti-PLA2R | Secondary causes |
| Infections | HBV, HCV, HIV, ASLO | Secondary causes |
| Metabolic | HbA1c, glucose, TFTs | Diabetes, thyroid |
| Electrophoresis | SPEP, UPEP, free light chains | Myeloma, amyloid |
| Imaging | Renal USS | Anatomy, size, obstruction |
| Biopsy | LM + IF + EM | Definitive histological diagnosis |